Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-05-13 16:15:29 ET · period of report 2026-05-13 · accession 0001938861-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-13 16:15 | 2026-05-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $78.16 | -500 | 78.4K | -0.6% | -$39.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-13 | S | D | 500 | $78.16 | 78,390 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. |